G. Tancini

G. Bonadonna, U. Veronesi, C. Brambilla, 1982, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

A clinical study of taxotere versus taxotere plus the antiprolactinemic agent bromocriptine in metastatic breast cancer pretreated with anthracyclines.

M. Vaghi, G. Gardani, A. Ardizzoia, 2002, Anticancer research.

Acute endocrine effects of interleukin-12 in cancer patients.

S. Barni, M. Mandalà, A. Ardizzoia, 1997, Journal of Biological Regulators and Homeostatic Agents.

[Description of a case of brown lipoma or hibernoma].

G. Tancini, L. Zingo, F. Talamazzi, 1967, Tumori.

Sequential laparoscopy and laparotomy combined with bone marrow biopsy in staging Hodgkin's disease.

G. Bonadonna, F. Rilke, L. Gennari, 1976, Cancer treatment reports.

[Association of laparoscopy and bone marrow biopsy in the staging of small-cell undifferentiated carcinoma of the lung. Evaluation of 116 consecutive cases].

S. Barni, P. Spinelli, S. Marchini, 1982, Tumori.

Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer

G. Bonadonna, U. Veronesi, C. Brambilla, 2005, Breast Cancer Research and Treatment.

Chemotherapy in prevention of the recurrence of resectable cancer.

G. Bonadonna, G. Tancini, A. Rossi, 1978, Annual review of medicine.

Zinc levels in serum during subcutaneous interleukin-2 immunotherapy of cancer

S. Barni, W. Pierpaoli, E. Mocchegiani, 1995, The International journal of biological markers.

Endocrine effects of a 24-hour intravenous infusion of interleukin-2 in the immunotherapy of cancer.

S. Barni, G. Maestroni, A. Conti, 1990, Anticancer research.

Prolactin Response to Thyrotropin-Releasing Hormone in Early and Advanced Human Breast Cancer

S. Barni, L. Ferri, S. Crispino, 1986, Tumori.

Weekly Doxorubicin Chemotherapy for Breast Cancer in Pregnancy. A Case Report

S. Barni, G. Zanetta, A. Ardizzoia, 1992, Tumori.

Immunoendocrine therapy with low-dose subcutaneous interleukin-2 plus melatonin of locally advanced or metastatic endocrine tumors.

S. Barni, G. Maestroni, P. Lissoni, 1995, Oncology.

The Pineal Gland and Breast Cancer: Serum Levels of Melatonin in Patients with Mammary Tumors and Their Relation to Clinical Characteristics

S. Barni, S. Crispino, P. Lissoni, 1989, The International journal of biological markers.

Clinical Study of Melatonin in Untreatable Advanced Cancer Patients

S. Barni, F. Fraschini, D. Esposti, 1987, Tumori.

A study on the relationship between the pineal gland and the opioid system in patients with cancer preliminary considerations

S. Barni, L. Ferri, F. Fraschini, 1988, Cancer.

Trials of adjuvant chemotherapy in breast cancer. The experience of the Istituto Nazionale Tumori of Milan.

G. Bonadonna, U. Veronesi, P. Valagussa, 1980, European journal of cancer.

Progress Report on the Palliative Therapy of 100 Patients with Neoplastic Effusions by Intracavitary Low-Dose Interleukin-2

S. Barni, G. Curigliano, M. Mandalà, 2001, Oncology.

Total pineal endocrine substitution therapy (TPEST) as a new neuroendocrine palliative treatment of untreatable metastatic solid tumor patients: a phase II study.

P. Lissoni, G. Tancini, F. Brivio, 2003, Neuro - endocrinology letters.

O R IGINAL AR T ICLE Total pineal endocrine substitution therapy (TPEST) as a new neuroendocrine palliative treatment of untreatable metastatic solid tumor patients: A phase II study

P. Lissoni, G. Tancini, F. Brivio, 2003 .

Paradoxical Stimulation of Prolactin Secretion by L–Dopa in Metastatic Prostate Cancer and Its Possible Role in Prostate–Cancer–Related Hyperprolactinemia

M. Mandalà, P. Lissoni, G. Tancini, 2000, European Urology.

A psychoncological study of lymphocyte subpopulations in relation to pleasure-related neurobiochemistry and sexual and spiritual profile to Rorschach's test in early or advanced cancer patients.

G. Gardani, P. Lissoni, G. Tancini, 2003, Journal of Biological Regulators and Homeostatic Agents.

Relation between Surgery-Induced Prolactin Increase and the Menstrual Cycle Phase at Time of Surgery in Premenopausal Breast Cancer

S. Barni, P. Lissoni, G. Tancini, 1991, The International journal of biological markers.

Intracavitary therapy of neoplastic effusions with cytokines: comparison among interferon alpha, beta and interleukin-2.

S. Barni, A. Ardizzoia, A. Rizzi, 1995, Supportive Care in Cancer.

Clinical Efficacy of the Aromatase Inhibitor Anastrozole in Relation to Prolactin Secretion in Heavily Pretreated Metastatic Breast Cancer

S. Barni, A. Ardizzoia, P. Lissoni, 1998, Tumori.

Adjuvant combination chemotherapy for operable breast cancer. Trials in progress at the Istituto Nazionale Tumori of Milan.

G. Bonadonna, U. Veronesi, C. Brambilla, 1981, Cancer treatment reports.

Effi cacy of monochemotherapy with docetaxel ( taxotere ) in relation to prolactin secretion in heavily pretreated metastatic breast cancer

G. Maestroni, A. Conti, M. Vaghi, 2001 .

Relationship between estrogen receptors and CMF adjuvant chemotherapy.

G. Bonadonna, C. Brambilla, P. Valagussa, 1984, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Serum Levels of Melatonin in Cancer Patients and their Relation to Body Sizes

S. Barni, F. Fraschini, S. Crispino, 1988, The International journal of biological markers.

Immunological effects of a single evening subcutaneous injection of low-dose interleukin-2 in association with the pineal hormone melatonin in advanced cancer patients.

S. Barni, G. Maestroni, A. Conti, 1992, Journal of biological regulators and homeostatic agents.

Neuroimmunotherapy with low-dose subcutaneous interleukin-2 plus melatonin in AIDS patients with CD4 cell number below 200/mm3: a biological phase-II study.

S. Barni, A. Ardizzoia, P. Lissoni, 1995, Journal of biological regulators and homeostatic agents.

CMF adjuvant programs at the Milan Cancer Institute.

G. Bonadonna, U. Veronesi, P. Valagussa, 1984, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Ten-year survival results in metastatic renal cell cancer patients treated with monoimmunotherapy with subcutaneous low-dose interleukin-2.

M. Vaghi, G. Gardani, A. Ardizzoia, 2002, Anticancer research.

Melatonin as a Modulator of Cancer Endocrine Therapy

S. Barni, A. Ardizzoia, P. Lissoni, 1997 .

Neuroimmunotherapy of human cancer with interleukin-2 and the neurohormone melatonin: its efficacy in preventing hypotension.

S. Barni, G. Maestroni, A. Conti, 1990, Anticancer research.

The pineal hormone melatonin in hematology and its potential efficacy in the treatment of thrombocytopenia.

S. Barni, P. Lissoni, G. Tancini, 1996, Recenti progressi in medicina.

Controlled studies with bleomycin in solid tumors and lymphomas.

G. Bonadonna, E. Bajetta, G. Tancini, 1976, Progress in biochemical pharmacology.

Chemotherapy and Angiogenesis in Advanced Cancer: Vascular Endothelial Growth Factor (VEGF) Decline as Predictor of Disease Control during Taxol Therapy in Metastatic Breast Cancer

G. Gardani, A. Ardizzoia, P. Lissoni, 2000, The International journal of biological markers.